創始于1938年,專注于醫藥及保健產品的生產、分銷及零售的大型綜合醫藥公司,產品組合包括化學藥品/中藥/生物制劑以及營養保健品
華潤醫藥集團有限公司(香港聯合交易所股份代碼:3320.HK)是中國領先的綜合醫藥公司,業務范疇覆蓋醫藥及保健產品的生產、分銷及零售。自上市以來,華潤醫藥(yao)集已獲納入(ru)多(duo)個重要資(zi)(zi)本市場指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu),包括:恒(heng)生(sheng)(sheng)綜合大(da)型(xing)(xing)股(gu)(gu)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)成(cheng)份股(gu)(gu)、恒(heng)生(sheng)(sheng)中(zhong)國(guo)內地醫(yi)療保健指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)、恒(heng)生(sheng)(sheng)醫(yi)療保健指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)、富時(shi)全(quan)球股(gu)(gu)票(piao)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)(大(da)型(xing)(xing)股(gu)(gu))、富時(shi)環球指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)、富時(shi)全(quan)球指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)全(quan)指(zhi)(zhi)(zhi)(zhi)(zhi)、摩根士丹利資(zi)(zi)本國(guo)際(MSCI)中(zhong)國(guo)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)成(cheng)份股(gu)(gu)、恒(heng)生(sheng)(sheng)港(gang)股(gu)(gu)通(tong)(tong)指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)、恒(heng)生(sheng)(sheng)港(gang)股(gu)(gu)通(tong)(tong)中(zhong)國(guo)內地公司指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)、恒(heng)生(sheng)(sheng)港(gang)股(gu)(gu)通(tong)(tong)非AH股(gu)(gu)公司指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)以及恒(heng)生(sheng)(sheng)港(gang)股(gu)(gu)通(tong)(tong)新(xin)經濟指(zhi)(zhi)(zhi)(zhi)(zhi)數(shu)(shu)(shu)系列(lie)。
華潤醫藥集旗下擁有(you)(you)(you)華(hua)(hua)潤(run)(run)醫藥(yao)(yao)(yao)商業(ye)集團(tuan)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)、華(hua)(hua)潤(run)(run)三九醫藥(yao)(yao)(yao)股(gu)份(fen)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(000999.SZ)、華(hua)(hua)潤(run)(run)雙鶴(he)藥(yao)(yao)(yao)業(ye)股(gu)份(fen)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(600062.SH)、華(hua)(hua)潤(run)(run)江中(zhong)(zhong)制藥(yao)(yao)(yao)集團(tuan)有(you)(you)(you)限(xian)(xian)責任公(gong)(gong)(gong)司(si)、東阿阿膠股(gu)份(fen)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(000423.SZ)、華(hua)(hua)潤(run)(run)紫(zi)竹藥(yao)(yao)(yao)業(ye)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)、華(hua)(hua)潤(run)(run)生物(wu)醫藥(yao)(yao)(yao)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)、中(zhong)(zhong)國(guo)醫藥(yao)(yao)(yao)研究開發中(zhong)(zhong)心有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)等企業(ye)。
2020年(nian),華(hua)潤醫藥集團(tuan)實現營業收入(ru)2004.23億港(gang)幣,年(nian)內利潤53.24億港(gang)幣。
華潤醫藥集的制造業務涵蓋研發、生產及銷售醫藥產品。產品組合包括化學藥品、中藥、生物制劑以及營養保健品,覆蓋廣泛治療領域,包括心血管、消化道和新陳代謝、大容量靜脈輸注、兒科、呼吸系統等。此外,華潤醫藥集(ji)擁有(you)多個(ge)品牌,包括(kuo)“三九”、“東阿(a)阿(a)膠”、“雙(shuang)鶴”、“江中”及“紫竹”。
華潤(run)醫(yi)藥(yao)集經營著一個由176個物流中心構成的全國性分銷網絡,戰略性覆蓋中國28個省、直轄市及自治區。憑借產品供應及廣泛的分銷網絡,華潤醫(yi)藥集向中國醫院及其他醫療機構直接分銷產品。另外,華潤(run)醫藥集經營中國大型零售藥房網絡之一,華潤醫(yi)藥集以“華潤堂”、“醫(yi)保全(quan)新”、“禮安連(lian)鎖”和“同德堂”等全(quan)國(guo)或地區性的品牌來經營(ying)862家(jia)自營(ying)零售(shou)藥房。
“守護人類健康 提升生命質量”是華潤醫藥集的崇高使命。華潤醫(yi)藥集立足中國(guo)醫藥健(jian)康(kang)產(chan)(chan)業發(fa)展(zhan)和(he)變革機遇,積極布局(ju)產(chan)(chan)業鏈的(de)核心(xin)領(ling)域和(he)核心(xin)環節,堅持(chi)創新發(fa)展(zhan),充分發(fa)揮(hui)一(yi)體化業務布局(ju)的(de)協同效應,優化資源配置,加強國(guo)際合作,推動轉型升級,持(chi)續提升核心(xin)競(jing)爭力,致力于(yu)成(cheng)為中國(guo)醫藥健(jian)康(kang)產(chan)(chan)業的(de)引(yin)導者。